Progenics Pharmaceuticals

Progenics Plans to Seek Approval for Prostate Cancer Imaging Tool Following Phase III Results
BioSpace
Mon, 12/23/19 - 11:48 pm
Progenics Pharmaceuticals
prostate cancer
PyL
cancer imaging
diagnostics
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Tue, 07/3/18 - 11:04 am
Spark Therapeutics
Zogenix
Progenics Pharmaceuticals
SPK-8011
ZX008
Azedra
FDA
3 Things In Biotech, March 23: Booking 3 Pieces Of Bad News
GoinPharma
Sun, 03/25/18 - 11:24 am
biotech
FDA
Azedra
Progenics Pharmaceuticals
AbbVie
Rova-T
PharmaMar
This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results
Motley Fool
Sun, 07/20/14 - 09:14 am
Progenics Pharmaceuticals
Salix
Exelixis
Roche
Amgen
AbbVie
Shire
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
AbbVie
Enanta Pharmaceuticals
ABT-450
hepatitis C
Medivation
Xtandi
prostate cancer
Astellas
Geron
imetelstat
PSMA-ADC
Progenics Pharmaceuticals
Idenix
Progenics Pharmaceuticals' Data From a Phase 1 Study of PSMA ADC Presented at ASCO 2013
Yahoo/GlobeNewsWire
Sat, 06/1/13 - 12:15 pm
Progenics Pharmaceuticals
PSMA ADC
prostate cancer
Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index
Yahoo/GlobeNewsWire
Sat, 05/18/13 - 11:48 am
Progenics Pharmaceuticals
Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of PSMA ADC
Pipeline Review
Sun, 02/17/13 - 11:58 am
PSMA ADC
prostate cancer
Progenics Pharmaceuticals
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Motley Fool
Sun, 12/9/12 - 01:21 pm
Chelsea Therapeutics
Cell Therapeutics
Aeterna Zentaris
Progenics Pharmaceuticals
Aveo Pharmaceutical
Exelixis
This Week in Biotech: Part 2
Motley Fool
Sat, 11/17/12 - 01:49 pm
Clovis Oncology
Eli Lilly
Celgene
Nektar
AstraZeneca
Salix
Progenics Pharmaceuticals
Dynavax Technologies
Tranzyme
Progenics Plummets On Rejection Of New Use Of Relistor Drug
Bloomberg
Mon, 07/30/12 - 10:57 am
Progenics Pharmaceuticals
Relistor
Salix
opiod-induced constipation
Salix and Progenics Receive Complete Response Letter from FDA for Relistor sNDA
Yahoo/BusinessWire
Sat, 07/28/12 - 11:28 am
Progenics Pharmaceuticals
Salix
Relistor
opiod-induced constipation
constipation
28 Drugs Facing FDA Approval in 2012-2013
TheStreet.com
Tue, 07/24/12 - 09:52 am
FDA
Amarin
Horizon Pharma
Salix
Progenics Pharmaceuticals
Regeneron
Sanofi
Talon Therapeutics
Gilead
Pfizer
Ironwood
Celgene
NPS Pharmaceuticals
Navidea Biopharmaceuticals
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Vivus, Onyx, Amarin Await Key Dates in July
Minyanville
Tue, 07/3/12 - 11:43 am
Amarin
ONYX Pharmaceuticals
Vivus
Qnexa
AMR101
Arcalyst
Regeneron
Kyprolis
Salix
Relistor
Progenics Pharmaceuticals
Rayos
Roche
Lucentis
Horizon Pharma
4 Healthcare Stocks Fueling Growth On Strong Profitability
Seeking Alpha
Tue, 07/3/12 - 09:54 am
Elan
Forest Labs
Pozen
Progenics Pharmaceuticals
Biotech Stocks To Watch In 2012
Seeking Alpha
Mon, 02/6/12 - 11:20 am
Astellas
Array Biopharma
AstraZeneca
Celldex
Exelixis
Pfizer
Progenics Pharmaceuticals
Seattle Genetics
Synta
2-Star Stocks Poised to Plunge: Progenics?
Motley Fool
Wed, 12/21/11 - 10:56 am
Progenics Pharmaceuticals
Progenics, Salix Surge After Constipation Drug Shows Benefits in Trial
Bloomberg
Tue, 12/20/11 - 12:09 pm
Salix
Progenics Pharmaceuticals
methylnaltrexone
opiod-induced constipation
Progenics to trim staff, narrow focus to oncology
Yahoo/AP
Thu, 09/15/11 - 12:04 pm
layoffs
oncology
Progenics Pharmaceuticals

Pages